Award recordCONTRACT

SHIRE US INC.

PIID VA26212F1058· VHA· 262-NETWORK CONTRACT OFFICE 22· 6505 · DRUGS AND BIOLOGICALS· FY2011· $302,344 net obligations· UEI WCFDJASKTLE1· PA

Description

STANDING ORDER: VELAGLUCERASE(PRIVY) RX

First action · last action
2011-09-29 · 2013-11-27
Transactions
2
First transaction's obligation
$303,159
Base + all options value (sum of deltas)
$302,344
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5898X
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$303,159$0Base award · 2011-09-29 · this action $303,159 · running total $303,159Modification P00001 · 2013-11-27 · this action -$816 · running total $302,344
  • Base2011-09-29+$303,159= $303,159
  • Mod P000012013-11-27-$816= $302,344
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2011-09-29+$303,159$303,159STANDING ORDER: VELAGLUCERASE(PRIVY) RX
Mod P00001· FUNDING ONLY ACTION2013-11-27−$816$302,344STANDING ORDER: VELAGLUCERASE(PRIVY) RX

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI WCFDJASKTLE1)

AwardOffice · PSC / listingNet obligationsFY
36C24719K0070247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS$239,178FY2019
36C24719K0069247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS$240,449FY2019
36C25919P0342NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$56,485FY2019
36C25919P0315NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$19,416FY2019
36C25919P0266NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$19,936FY2019
36C25919P0183NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$28,990FY2019

Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26216J3405SANOFI VACCINES US INC.262-NETWORK CONTRACT OFFICE 22$209,679FY2016
VA26216P3483JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC.262-NETWORK CONTRACT OFFICE 22$14,960FY2016
VA26216E3967MCKESSON CORPORATION262-NETWORK CONTRACT OFFICE 22$20,913,958FY2016
VA26216P2987PETNET SOLUTIONS, INC.262-NETWORK CONTRACT OFFICE 22$58,136FY2016
VA26216E3446MCKESSON CORPORATION262-NETWORK CONTRACT OFFICE 22$11,612,703FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26212F1058_3600_V797P5898X_3600 · retrieved 2026-09-26.